In June 2012, Stryker Orthopaedics recalled the Stryker Rejuvenate Modular Primary Hip System and the Stryker ABG II modular hip stems. Thousands of persons in the U.S. were implanted with these devices from 2007 through 2012.
On November 3, 2014, a settlement was announced in the litigation against Stryker Corporation for the recall of its Rejuvenate and ABG II artificial hip implants. Under the settlement, Stryker will provide a base payment of $300,000 to patients that received the Rejuvenate or ABG II hip systems and underwent revision surgery by November 3, 2014, to remove and replace the devices.
July 16, 2014 (New York, NY) — Wendy Fleishman and Lexi Hazam, of the national plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP, announced today that over the past month 20 hip replacement patients represented by Lieff Cabraser have filed personal injury lawsuits against Stryker Orthopaedics. These suits charge that the company manufactured and sold defective artificial hip implants known as the Stryker Rejuvenate and Stryker ABG II hip implants. The patients hail from across the nation, including Alabama, California, Colorado, Illinois, New York, Ohio, Oregon, Pennsylvania, and Texas.